Toward Precision Pancreatic Cancer Care

Author: Robert Goldberg PhD
View More View Less
Volume/Issue:
Volume 20: Issue 5
Online Publication Date:
May 2022
DOI:
https://doi.org/10.6004/jnccn.2022.7019
Restricted access

Disclosures: Dr. Goldberg has disclosed not having any financial interests, arrangements, or affiliations with the manufacturers of any products discussed in this article or their competitors.

Correspondence: Robert Goldberg, PhD, Center for Medicine in the Public Interest, 308 East 38 Street, Suite 201, New York, NY 10016. Email: rgoldberg@cmpi.org

View associated content

  • 1.

    Schwartz NRM, Matrisian LM, Shrader EE, et al. Potential cost-effectiveness of risk-based pancreatic cancer screening in patients with new-onset diabetes. J Natl Compr Canc Netw 2022;20:451–459.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 2.

    Chari ST, Maitra A, Matrisian LM, et al. Early detection initiative: a randomized controlled trial of algorithm-based screening in patients with new onset hyperglycemia and diabetes for early detection of pancreatic ductal adenocarcinoma. Contemp Clin Trials 2022;113:106659.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 3.

    Jeon CY, Pandol SJ, Wu B, et al. The association of statin use after cancer diagnosis with survival in pancreatic cancer patients: a SEER-medicare analysis. PLoS One 2015;10:e0121873.

    • Search Google Scholar
    • Export Citation
Copyright:
Copyright © 2022 by the National Comprehensive Cancer Network 2022
Page Numbers:
2
Article Category:
Other
Print Publication Date:
01 May 2022
Online Publication Date:
May 2022
All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 493 493 493
PDF Downloads 287 287 287
EPUB Downloads 0 0 0